Figure 4.

Neutralizing auto-Abs against IFN-α2 and/or IFN-ω in the pediatric and adult general population. (A–H) Proportion by age of pediatric and adult individuals from the general population positive for neutralizing auto-Abs (in plasma 1/10) against (A) IFN-α2 and/or IFN-ω, at 10 ng/ml, for both sexes; (B) IFN-α2 and/or IFN-ω, at 10 ng/ml, for men or women; (C) IFN-α2 and/or IFN-ω, at 100 pg/ml, for both sexes; (D) IFN-α2 and/or IFN-ω, at 100 pg/ml, for men or women; (E) IFN-α2, at 100 pg/ml, for both sexes; (F) IFN-α2, at 100 pg/ml, for men or women; (G) IFN-ω, at 100 pg/ml, for both sexes; and (H) IFN-ω, at 100 pg/ml, for men or women.